DGAP-News: Raptor Pharmaceutical Corp. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference 2012
(firmenpresse) - Raptor Pharmaceutical Corp.
09.11.2012 20:21
---------------------------------------------------------------------------
NOVATO, Calif., 2012-11-09 20:20 CET (GLOBE NEWSWIRE) --
Raptor Pharmaceutical Corp. ('Raptor' or the 'Company') (Nasdaq:RPTP), today
announced that Julie Anne Smith, Executive Vice President, Strategy and Chief
Operating Officer of Raptor, will present an overview of the Company at the
Lazard Capital Markets 9th Annual Healthcare Conference in New York, NY at The
Pierre hotel. Raptor's presentation will take place on Wednesday, November 14,
2012 beginning at 9:30 a.m. ET.
A live audio webcast and 14-day archive of the Lazard presentation will be
available at http://ir.raptorpharma.com/events.cfm
About Raptor Pharmaceutical Corp.
Raptor Pharmaceutical Corp. ('Raptor') (Nasdaq:RPTP) seeks to research,
develop, and provide access to medicines that improve life for patients with
severe and rare disorders. Raptor currently has product candidates in clinical
development designed to potentially treat nephropathic cystinosis,
non-alcoholic steatohepatitis, Huntington's Disease, and aldehyde dehydrogenase
deficiency.
Raptor's preclinical programs are based upon bioengineered novel drug
candidates and drug-targeting platforms derived from the human
receptor-associated protein and related proteins that are designed to target
cancer and infectious diseases.
For additional information, please visit www.raptorpharma.com.
The Raptor Pharmaceutical Corp. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=7180
CONTACT: Trout Group (investors)
Lauren Glaser
(646) 378-2972
lglaser(at)troutgroup.com
EVC Group (media)
Janine McCargo
(646) 688-0425
jmccargo(at)evcgroup.com
News Source: NASDAQ OMX
09.11.2012 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Raptor Pharmaceutical Corp.
United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US75382F1066
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 09.11.2012 - 20:21 Uhr
Sprache: Deutsch
News-ID 201784
Anzahl Zeichen: 5728
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 180 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Raptor Pharmaceutical Corp. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference 2012"
steht unter der journalistisch-redaktionellen Verantwortung von
Raptor Pharmaceutical Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
